10
Total investments
9
Early stage
1
Mid stage
0
Late stage
12y
Years active
Portfolio
10 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jan 2024
PIEZOLABS revolutionary vascular devices self-generate an electric potential upon implantation, precisely managing blood interaction. Tailored to either prevent or promote clot formation based on patient needs, it potentially eliminates / reduce the need for dual antiplatelet therapy (DAPT) post-procedure, reducing bleeding and thrombotic risks. Experience the future potential of vascular health with our cutting-edge technology.
Angle investor
May 2021
CNS disorders are often treated ineffectively by trial-and-error, causing prolonged patient distress and high healthcare costs. Neumarker aims to transform the treatment of CNS disorders through its cutting-edge brain biomarker discovery platform, powered by AI. By identifying predictive brain biomarkers, we can personalize treatment for each patient and accelerate drug development by efficient clinical trials. Neumarker is committed to advancing precision neuromedicine through collaborations with drug developers, clinicians and academic researchers.
Angel Investor
Dec 2020
Telesair, Inc. is a Southern California based medical device company in stealth mode, that is developing breakthrough respiratory care solutions to help move patients from hospital to home sooner. Designed by respiratory veterans in both R&D and commercialization, our solutions elevate the existing standard of care by improving outcomes for patients and the health system.
Early investor
Dec 2020
What is the future of orthodontics?
We believe that the future is what happens
When medicine, art, and technology converge.
The patient is at the center of every decision,
So the standard is raised to personalized care.
The instrument becomes as sophisticated as the specialty,
So that technology is in the hands of the experts.
A community of trailblazers
Doctors, designers, and engineers
United to materialize a vision.
We are all LightForce. And together, the future is ours to create.
--
Delivering a patient-specific prescription for each case, the LightForce system is unlike anything youve ever used. Using next generation 3D printing technology, each bracket is custom created directly from your digital treatment plan. Designed to enhance treatment efficiency and minimize time-consuming adjustments, every phase of treatment is in your control.
LightForce: the worlds first, fully-customized, 3D printed brackets.
Board Member & angel investor
Aug 2020
In July 2020, MK Vision Jsc. was founded as a part of the MK Group. Our primary emphasis is on developing hardware and implementing advanced camera technology that incorporates artificial intelligence (AI cameras). MK Vision is dedicated to introducing cutting-edge camera products of premium quality, aimed at fulfilling Vietnams unique surveillance and management requirements.
Angel Investor
May 2019
Noah Medical is building the future of medical robotics. Our next generation robotic platform targets early diagnosis and treatment of patients across multiple indications.
Based in Silicon Valley and backed by well-known institutional investors, our incredibly talented team of 70+ engineers, innovators and industry leaders brings years of experience from the top healthcare companies in the world.
Angle investor
May 2017
GV20 Therapeutics (https://gv20tx.com) was incorporated in 2016 with sites in Cambridge, USA, and Shanghai, China. The company utilizes high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. GV20s proprietary antibody drug discovery engine has helped establish a solid portfolio of immuno-oncology antibody drug candidates for cancer treatment.
Board Member & Angel Investor
Nov 2015
Yarbo is a smart, all-season yard care robot that offers a hassle-free solution for yard maintenance. With interchangeable modules for snow removal, lawn mowing, and leaves blowing, it eliminates the need for multiple pieces of equipment, making yard work easy, time-saving, and safe.
Yarbo was founded by Allen Huang with a vision to create autonomous robots for residential yard maintenance. Starting with the aspiration to create an autonomous snow blower, Yarbos journey has been marked by transformative breakthroughs which have reshaped the yard maintenance market. From the initial Snowbot version to the latest Yarbo model, our team has remained dedicated to advancement and a strong customer-centric ethos.
With the innovative concept of interchangeable modules, Yarbo continues unweaving our commitment to pushing boundaries, fostering partnerships, and influencing industries, all while staying true to its customer-focused core values that have been the foundation of our success.
Follow us in exploring a world of innovation, ground-breaking, and inspiration as we share our latest updates and endeavors.
Experience ยท 11 entries
All (11)
Investments (10)
Founder (1)
Board (3)
2024
Board Observer
Jan 2024
PIEZOLABS revolutionary vascular devices self-generate an electric potential upon implantation, precisely managing blood interaction. Tailored to either prevent or promote clot formation based on patient needs, it potentially eliminates / reduce the need for dual antiplatelet therapy (DAPT) post-procedure, reducing bleeding and thrombotic risks. Experience the future potential of vascular health with our cutting-edge technology.
2021
Angle investor
May 2021
CNS disorders are often treated ineffectively by trial-and-error, causing prolonged patient distress and high healthcare costs. Neumarker aims to transform the treatment of CNS disorders through its cutting-edge brain biomarker discovery platform, powered by AI. By identifying predictive brain biomarkers, we can personalize treatment for each patient and accelerate drug development by efficient clinical trials. Neumarker is committed to advancing precision neuromedicine through collaborations with drug developers, clinicians and academic researchers.
2020
Angel Investor
Dec 2020
Telesair, Inc. is a Southern California based medical device company in stealth mode, that is developing breakthrough respiratory care solutions to help move patients from hospital to home sooner. Designed by respiratory veterans in both R&D and commercialization, our solutions elevate the existing standard of care by improving outcomes for patients and the health system.
Early investor
Dec 2020
What is the future of orthodontics?
We believe that the future is what happens
When medicine, art, and technology converge.
The patient is at the center of every decision,
So the standard is raised to personalized care.
The instrument becomes as sophisticated as the specialty,
So that technology is in the hands of the experts.
A community of trailblazers
Doctors, designers, and engineers
United to materialize a vision.
We are all LightForce. And together, the future is ours to create.
--
Delivering a patient-specific prescription for each case, the LightForce system is unlike anything youve ever used. Using next generation 3D printing technology, each bracket is custom created directly from your digital treatment plan. Designed to enhance treatment efficiency and minimize time-consuming adjustments, every phase of treatment is in your control.
LightForce: the worlds first, fully-customized, 3D printed brackets.
Show all 11 entries โ
Investment activity
2014โ2024 ยท 10 investments
Recent (last 2 years)Earlier
